Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex
Clinical trial NCT03284164 · COMPLETED
Trial details
- NCT number
- NCT03284164
- Sponsor
- ContraVir Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-28
- Primary completion
- 2018-01-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.